Identification of Individual Exosome‐Like Vesicles by Surface Enhanced Raman Spectroscopy. Issue 24 (12th May 2016)

• Record Type: Journal Article
• Authors: Stremersch, Stephan; Marro, Monica; Pinchasik, Bat‐El; Baatsen, Pieter; Hendrix, An; De Smedt, Stefaan C.; Loza‐Alvarez, Pablo; Skirtach, Andre G.; Raemdonck, Koen; Braeckmans, Kevin
• Is Part Of: Small. Volume 12:Issue 24(2016)
• Page Start: 3292
• Page End: 3301
• Publication Date: 2016-05-12
• Subjects: diagnostics -- exosome‐like vesicles -- gold nanoparticles -- multivariate statistical analysis -- surface enhanced Raman spectroscopy; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201600393
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract : Exosome‐like vesicles (ELVs) are a novel class of biomarkers that are receiving a lot of attention for the detection of cancer at an early stage. In this study the feasibility of using a surface enhanced Raman spectroscopy (SERS) based method to distinguish between ELVs derived from different cellular origins is evaluated. A gold nanoparticle based shell is deposited on the surface of ELVs derived from cancerous and healthy cells, which enhances the Raman signal while maintaining a colloidal suspension of individual vesicles. This nanocoating allows the recording of SERS spectra from single vesicles. By using partial least squares discriminant analysis on the obtained spectra, vesicles from different origin can be distinguished, even when present in the same mixture. This proof‐of‐concept study paves the way for noninvasive (cancer) diagnostic tools based on exosomal SERS fingerprinting in combination with multivariate statistical analysis. Abstract : A method is used to obtain a surface enhanced Raman spectrum of a single, nanosized exosome‐like vesicle (ELV) while maintaining individual ELVs in suspension. Based on these spectra, ELVs derived from different cell types can be distinguished, hence allowing the identification and quantification of specific (cancerous) ELVs in a mixture.